Senior Director, HEOR – Payer & Outcomes Strategy

BioMarin Pharmaceutical Inc.

Greater London

Hybrid

GBP 140,000 - 200,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

BioMarin Pharmaceutical Inc. is seeking a Senior Director of Health Economics and Outcomes Research in London.

You will lead payer evidence strategies, shape patient-relevant outcomes, and ensure alignment with regulatory and HTA needs while partnering with cross-functional teams across Value & Access, Commercial, Medical Affairs, and Clinical Development. With 12+ years in pharma and a specialty in HEOR, you will influence strategic decisions, manage external partnerships, and drive PRO

Qualifications

  • 12+ years in pharma with 7+ years in HEOR roles and at least 5 years in patient-relevant outcomes research.
  • Advanced degree in health economics, outcomes research, epidemiology, public health, or related field.
  • Deep understanding of market access, value and global HTA frameworks.
  • Experience developing and executing PRO measures to support HTA and regulatory decisions.
  • Proven ability to influence and align senior cross-functional stakeholders.
  • Rare disease experience preferred.

Responsibilities

  • Lead payer evidence strategies aligned with brand and Value & Access priorities for early-stage assets.
  • Collaborate with Value & Access, Commercial, Medical Affairs, Clinical Development, Regulatory, and Patient Advocacy.
  • Drive HTA requirements and health utility measurement understanding across programs.
  • Oversee PRO endpoints planning and trial integration for access enablement.
  • Lead external interactions with HTA agencies and regulatory bodies; prepare briefing materials.
  • Shape strategic scientific communications and publish research in peer‑reviewed journals.

Skills

Leadership
Stakeholder management
Cross-functional collaboration
Strategic thinking
Communication
Project management

Education

Advanced degree in health economics or related field

Job description

BioMarin Pharmaceutical Inc. is seeking a Senior Director of Health Economics and Outcomes Research in London.

You will lead payer evidence strategies, shape patient-relevant outcomes, and ensure alignment with regulatory and HTA needs while partnering with cross-functional teams across Value & Access, Commercial, Medical Affairs, and Clinical Development. With 12+ years in pharma and a specialty in HEOR, you will influence strategic decisions, manage external partnerships, and drive PRO

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Hybrid HEOR Associate Director — Payer & Outcomes Strategy
Hybrid HEOR Associate Director — Payer & Outcomes Strategy

BioMarin Pharmaceutical Inc. • Greater London

Hybrid
GBP 90,000 - 120,000
HEOR Associate Director: Payer Evidence & Access Lead
HEOR Associate Director: Payer Evidence & Access Lead

Biomarin • Greater London

Hybrid
GBP 90,000 - 130,000
Associate Director, Health Economics & Outcomes Research (Heor)
Associate Director, Health Economics & Outcomes Research (Heor)

Biomarin • England

On-site
GBP 90,000 - 130,000
Senior Director, Health Economics & Outcomes Research (HEOR)
Senior Director, Health Economics & Outcomes Research (HEOR)

BioMarin Pharmaceutical Inc. • Greater London

On-site
GBP 140,000 - 200,000
Associate Director, Health Economics & Outcomes Research (HEOR)
Associate Director, Health Economics & Outcomes Research (HEOR)

BioMarin Pharmaceutical Inc. • Greater London

On-site
GBP 90,000 - 120,000
Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR Strategy Lead — Payer & HTA (Hybrid)
Global HEOR Strategy Lead — Payer & HTA (Hybrid)

UCB S.A. • Reading

Hybrid
GBP 90,000 - 140,000
Hybrid work model (40% office)
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Global HEOR Director: Value, Access & Payer Strategy
Global HEOR Director: Value, Access & Payer Strategy

Ipsen • Greater London

On-site
GBP 140,000 - 200,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Princes Risborough

On-site
GBP 90,000 - 130,000